102 related articles for article (PubMed ID: 526922)
1. Alterations in the toxicity and antitumor activity of methyl-CCNU in mice following pretreatment with either phenobarbital or SKF 525A.
Klubes P; Miller HG; Cerna I; Trevithick J
Cancer Treat Rep; 1979; 63(11-12):1901-7. PubMed ID: 526922
[No Abstract] [Full Text] [Related]
2. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
Siemann DW
Cancer Treat Rep; 1983 Mar; 67(3):259-65. PubMed ID: 6831472
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
Rose WC; Trader MW; Dykes DJ; Laster WR; Schabel FM
Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
[TBL] [Abstract][Full Text] [Related]
4. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
Panasci LC; Green D; Schein PS
J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
[TBL] [Abstract][Full Text] [Related]
5. Qualitative and quantitative toxicity of sublethal doses of methyl-CCNU in BDF1 mice.
Denine EP; Harrison SD; Peckham JC
Cancer Treat Rep; 1977; 61(3):409-17. PubMed ID: 872140
[No Abstract] [Full Text] [Related]
6. Interaction of secalonic acid D with phenobarbital, 3-methyl cholanthrene, and SKF-525A in mice.
Reddy CS; Reddy RV; Hayes AW
J Toxicol Environ Health; 1983; 12(4-6):687-94. PubMed ID: 6668617
[TBL] [Abstract][Full Text] [Related]
7. Biological and biochemical properties of the 2-hydroxyl metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Heal JM; Fox PA; Doukas D; Schein PS
Cancer Res; 1978 Apr; 38(4):1070-4. PubMed ID: 147730
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
Schein PS; Panasci L; Woolley PV; Anderson T
Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of ICRF-159 in combination with 1.3 bis-(2-chloroethyl)-1-nitrosourea (MeCCNU).
Paul AR; Catalano RB; Engstrom PF
Cancer Clin Trials; 1978; 1(2):99-102. PubMed ID: 757145
[TBL] [Abstract][Full Text] [Related]
10. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
Belt RJ; Stephens R
Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of chlorpromazine, caffeine, and methyl-CCNU in disseminated melanoma.
Cohen MH; Schoenfeld D; Wolter J
Cancer Treat Rep; 1980 Jan; 64(1):151-3. PubMed ID: 6991102
[TBL] [Abstract][Full Text] [Related]
12. Nitrosoureas: a review of experimental antitumor activity.
Schabel FM
Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
[TBL] [Abstract][Full Text] [Related]
13. Use of phenobarbital and high doses of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the treatment of brain tumor-bearing mice.
Muller PJ; Tator CH; Bloom ML
Cancer Res; 1983 May; 43(5):2068-71. PubMed ID: 6831437
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of methylnitrosourea antitumor agents with reduced murine bone marrow toxicity.
Panasci LC; Fox PA; Schein PS
Cancer Res; 1977 Sep; 37(9):3321-8. PubMed ID: 141978
[No Abstract] [Full Text] [Related]
15. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
Lin TS; Fischer PH; Marsh JC; Prusoff WH
Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
[TBL] [Abstract][Full Text] [Related]
16. The effect of phenobarbital on cyclophosphamide antitumor activity.
Alberts DS; van Daalen Wetters T
Cancer Res; 1976 Aug; 36(8):2785-9. PubMed ID: 1277188
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antileukemic activity of combinations of two nitrosoureas.
Wheeler GP; Schabel FM; Trader MW
Cancer Treat Rep; 1981; 65(7-8):591-9. PubMed ID: 6454482
[TBL] [Abstract][Full Text] [Related]
18. The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.
Field RB; Gang M; Kline I; Venditti JM; Waravdekar VS
J Pharmacol Exp Ther; 1972 Feb; 180(2):475-83. PubMed ID: 5010684
[No Abstract] [Full Text] [Related]
19. Alterations in 3H-thymidine incorporation into DNA induced by methyl CCNU (1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea) in normal and tumorous tissues in vivo.
Young RC; Goldberg D; Grotzinger KR
Cell Tissue Kinet; 1976 Jul; 9(4):325-32. PubMed ID: 1277265
[TBL] [Abstract][Full Text] [Related]
20. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
Schein PS; McMenamin MG; Anderson T
Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
[No Abstract] [Full Text] [Related]
[Next] [New Search]
